Open Access
TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
Тип публикации: Journal Article
Дата публикации: 2022-10-19
PubMed ID:
36291908
Cancer Research
Oncology
Краткое описание
The death ligand tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF cytokine superfamily, has long been recognized for its potential as a cancer therapeutic due to its low toxicity against normal cells. However, its translation into a therapeutic molecule has not been successful to date, due to its short in vivo half-life associated with insufficient tumor accumulation and resistance of tumor cells to TRAIL-induced killing. Nanotechnology has the capacity to offer solutions to these limitations. This review provides a perspective and a critical assessment of the most promising approaches to realize TRAIL’s potential as an anticancer therapeutic, including the development of fusion constructs, encapsulation, nanoparticle functionalization and tumor-targeting, and discusses the current challenges and future perspectives.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
|
|
|
Cancers
2 публикации, 5.88%
|
|
|
Biomedicine and Pharmacotherapy
2 публикации, 5.88%
|
|
|
Biomaterials
1 публикация, 2.94%
|
|
|
Nature Communications
1 публикация, 2.94%
|
|
|
Food Science and Technology
1 публикация, 2.94%
|
|
|
Journal of Controlled Release
1 публикация, 2.94%
|
|
|
Chemical Biology and Drug Design
1 публикация, 2.94%
|
|
|
Drug Resistance Updates
1 публикация, 2.94%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 2.94%
|
|
|
Translational Oncology
1 публикация, 2.94%
|
|
|
Scientific Reports
1 публикация, 2.94%
|
|
|
Anti-Cancer Agents in Medicinal Chemistry
1 публикация, 2.94%
|
|
|
Biochemistry (Moscow)
1 публикация, 2.94%
|
|
|
Biochemical Pharmacology
1 публикация, 2.94%
|
|
|
Heliyon
1 публикация, 2.94%
|
|
|
Биохимия
1 публикация, 2.94%
|
|
|
Molecular Pharmaceutics
1 публикация, 2.94%
|
|
|
Phytochemicals in Agriculture and Food [Working Title]
1 публикация, 2.94%
|
|
|
Archives of Biochemistry and Biophysics
1 публикация, 2.94%
|
|
|
Clinical Medicine Insights: Oncology
1 публикация, 2.94%
|
|
|
Russian Chemical Reviews
1 публикация, 2.94%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
1 публикация, 2.94%
|
|
|
World Journal of Clinical Oncology
1 публикация, 2.94%
|
|
|
Communications Medicine
1 публикация, 2.94%
|
|
|
Advanced Therapeutics
1 публикация, 2.94%
|
|
|
Translational Andrology and Urology
1 публикация, 2.94%
|
|
|
Molecular Aspects of Medicine
1 публикация, 2.94%
|
|
|
International Journal of Molecular Sciences
1 публикация, 2.94%
|
|
|
ACS Biomaterials Science and Engineering
1 публикация, 2.94%
|
|
|
1
2
|
Издатели
|
2
4
6
8
10
12
|
|
|
Elsevier
12 публикаций, 35.29%
|
|
|
Springer Nature
4 публикации, 11.76%
|
|
|
MDPI
3 публикации, 8.82%
|
|
|
Wiley
2 публикации, 5.88%
|
|
|
American Chemical Society (ACS)
2 публикации, 5.88%
|
|
|
SciELO
1 публикация, 2.94%
|
|
|
Bentham Science Publishers Ltd.
1 публикация, 2.94%
|
|
|
Pleiades Publishing
1 публикация, 2.94%
|
|
|
The Russian Academy of Sciences
1 публикация, 2.94%
|
|
|
IntechOpen
1 публикация, 2.94%
|
|
|
SAGE
1 публикация, 2.94%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.94%
|
|
|
Cold Spring Harbor Laboratory
1 публикация, 2.94%
|
|
|
Baishideng Publishing Group
1 публикация, 2.94%
|
|
|
AME Publishing Company
1 публикация, 2.94%
|
|
|
American Association for the Advancement of Science (AAAS)
1 публикация, 2.94%
|
|
|
2
4
6
8
10
12
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
34
Всего цитирований:
34
Цитирований c 2025:
12
(35.29%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Alizadeh Zeinabad H., Szegezdi E. TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems // Cancers. 2022. Vol. 14. No. 20. p. 5125.
ГОСТ со всеми авторами (до 50)
Скопировать
Alizadeh Zeinabad H., Szegezdi E. TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems // Cancers. 2022. Vol. 14. No. 20. p. 5125.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.3390/cancers14205125
UR - https://doi.org/10.3390/cancers14205125
TI - TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
T2 - Cancers
AU - Alizadeh Zeinabad, Hojjat
AU - Szegezdi, Eva
PY - 2022
DA - 2022/10/19
PB - MDPI
SP - 5125
IS - 20
VL - 14
PMID - 36291908
SN - 2072-6694
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2022_Alizadeh Zeinabad,
author = {Hojjat Alizadeh Zeinabad and Eva Szegezdi},
title = {TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems},
journal = {Cancers},
year = {2022},
volume = {14},
publisher = {MDPI},
month = {oct},
url = {https://doi.org/10.3390/cancers14205125},
number = {20},
pages = {5125},
doi = {10.3390/cancers14205125}
}
Цитировать
MLA
Скопировать
Alizadeh Zeinabad, Hojjat, et al. “TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems.” Cancers, vol. 14, no. 20, Oct. 2022, p. 5125. https://doi.org/10.3390/cancers14205125.